Barclays’s VIROPHARMA INC VPHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-910,864
Closed -$44.6M 7960
2013
Q4
$44.6M Buy
910,864
+617,763
+211% +$27.6M 0.05% 382
2013
Q3
$11.4M Buy
293,101
+208,480
+246% +$6.82M 0.01% 1049
2013
Q2
$2.42M Buy
+84,621
New +$2.23M ﹤0.01% 2323

Barclays's VPHM Position: Q1 2014 in Review

Barclays sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 910,864 shares — an estimated $44.6M sold.

Barclays first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $44.6M in Q4 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

  • Barclays reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
  • Barclays sold 910,864 VIROPHARMA INC shares in Q1 2014, an estimated $44.6M.
  • Barclays first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
  • Barclays's VIROPHARMA INC position peaked at $44.6M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.